<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Pathologic collagen remodeling has been involved in the occurrence of <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> and <z:hpo ids='HP_0001645'>sudden cardiac death</z:hpo> in <z:hpo ids='HP_0001635'>heart failure</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of the study was to investigate the relationship between malignant <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> and cardiac collagen turnover indexes, expressing specific types of derangement in collagen <z:mp ids='MP_0001532'>physiology</z:mp>, in stable patients with an implantable cardioverter-defibrillator (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Seventy-four patients with an <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> and <z:hpo ids='HP_0001635'>heart failure</z:hpo> were studied </plain></SENT>
<SENT sid="3" pm="."><plain>They had <z:hpo ids='HP_0001677'>coronary artery disease</z:hpo> (n = 42) or <z:hpo ids='HP_0001644'>dilated cardiomyopathy</z:hpo>, New York Heart Association classes I and II, and left ventricular ejection fraction 29% Â± 1% </plain></SENT>
<SENT sid="4" pm="."><plain>An <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> had been implanted for secondary (n = 36) or primary prevention of <z:hpo ids='HP_0001645'>sudden cardiac death</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>We assessed (1) markers of collagen types I and III synthesis and their ratio: procollagen type I carboxyterminal <z:chebi fb="7" ids="16670">peptide</z:chebi> (PICP), procollagen type III aminoterminal <z:chebi fb="7" ids="16670">peptide</z:chebi> (PIIINP), and PICP/PIIINP; (2) markers of collagen degradation, degradation inhibition, and their ratio: matrix metalloproteinase 9 (MMP-9), tissue inhibitor of matrix metalloproteinase (TIMP) 1 (TIMP-1), and MMP-9/TIMP-1 </plain></SENT>
<SENT sid="6" pm="."><plain>Patients were prospectively followed up for 1 year </plain></SENT>
<SENT sid="7" pm="."><plain>The number of episodes necessitating appropriate interventions for ventricular tachyarrhythmias (&gt;170 beat/min) was related to the assessed parameters </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: Multivariate analysis revealed a significant relation between the number of tachyarrhythmic episodes and MMP-9/TIMP-1 (P = .007), PICP/PIIINP (P = .007), and ejection fraction (P = .04) </plain></SENT>
<SENT sid="9" pm="."><plain>No other significant relation was observed between <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> and the remaining parameters </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: In <z:hpo ids='HP_0001635'>heart failure</z:hpo>, biochemical markers indicative of a deranged equilirium in myocardial collagen deposition/degradation and collagen I/III synthesis are related to ventricular arrhythmogenesis </plain></SENT>
<SENT sid="11" pm="."><plain>Further studies are needed to investigate their predictive ability </plain></SENT>
</text></document>